News

Siemens, KLAS, preferred vendor, partnership agreements

In a recent survey by the KLAS research firm, Siemens Healthcare was the designated vendor for healthcare providers in 47 percent of current partnership agreements. Moreover, the survey also found...

Aspire, Pablo Uceda, DFW Vascular, deep vein thrombosis, thrombectomy

Pablo Uceda, M.D., vascular surgeon with DFW Vascular, Dallas, Texas, was successful in using a new device to clear blood clots out of a patient's legs.

congenital heart, adults, early detection, Penn State Hershey, CHD

At one time, many children born with congenital heart disease (CHD) suffered from issues that carried fatal prognoses. Thanks to technological advancements in the past 30 to 40 years, Elizabeth...

VenaSeal, varicose veins, Covidien, FDA

The U.S. Food and Drug Administration (FDA) approved the VenaSeal closure system to permanently treat varicose veins of the legs by sealing the affected superficial veins using an adhesive agent...

Radiance Ultra, NDS Surgical Imaging, flat panel displays, hybrid OR

NDS Surgical Imaging (NDSsi) announced the release of the 27-inch Radiance Ultra, a next-generation surgical visualization platform. The ultra-high level of brightness from the LED backlight...

TAVR, TAVI, acc, ACC.15, corevalve

Key data from many transcatheter aortic valve replacement (TAVR) clinical trials will be presented as late-breakers at the American College of Cardiology (ACC) Scientific Session this weekend,...

Aspire, Control Medical, thrombectomy, atherectomy devices, cath lab

George Adams, M.D., an interventional cardiologist with North Carolina Heart and Vascular, successfully treated a patient having an acute myocardial infarction (AMI) with the Aspire Mechanical...

VTEC, NYU Langone, venous therapies, deep vein thrombosis, DVT, PE

NYU Langone Medical Center has announced the creation of a new multidisciplinary Venous Thromboembolic Disease Center (VTEC) to treat those with life-threatening blood clots. The new...

ResQCPR System, resuscitation devices, cardiac arrest, CPR, FDA

The U.S. Food and Drug Administration (FDA) approved the ResQCPR System, a system of two devices for first responders to use while performing cardiopulmonary resuscitation (CPR) on cardiac arrest...

Corindus, CorPath, trial, cath lab, PCI, robotic

Corindus Vascular Robotics Inc. announced it has initiated a clinical trial of its CorPath System in peripheral vascular interventions. The study is currently enrolling patients at the...

Merck announced results from two post-hoc analyses of the TRA 2°P TIMI 50 (Thrombin Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) trial of Zontivity (vorapaxar...

PE, pulmonary embolism, thrombolysis, Ekos, Ekosonic

The continuity within clinical conference topics from year to year and how presentations augment one another tells us a lot about where medicine is headed. Pulmonary embolism (PE) therapies were a...

Biotronik, Passeo-18 Lux, DCB, BIOLUX P-I, trial, drug eluting, balloon catheter

Biotronik announced that results of its BIOLUX P-I clinical study have been published in the Journal of Endovascular Therapy. BIOLUX P-I was a prospective, international, multi-center,...

Tryton Side Branch Stent, Pivotal IDE, bifurcation stent, bifurcation stent

Tryton Medical Inc. announced that results from the company’s pivotal clinical trial for the Tryton Side Branch Stent were published in the Journal of the American College of Cardiology...

A study being presented at the Society of Interventional Radiology’s annual scientific meeting says 3-D printing could become a powerful tool in customizing interventional radiology treatments to...

CompView Medical, NuCart, mounts, flat panel displays, hybrid OR, mobile boom

CompView Medical (CVM) introduced an all-in-one equipment manager, visualization and ergonomic boom system — the NuCart.

interventional radiology, Mayo Clinic, aprons, dose, cath lab

Frequent use of lead aprons in the interventional lab and radiology departments to protect against radiation exposure is associated with increased musculoskeletal pain, according to a study...

Cardinal Health announced plans to acquire Johnson & Johnson’s Cordis business, a leading global manufacturer of cardiology and endovascular devices, for $1.94 billion in cash.